Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE

NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE

Standard Dose
EQ 3.5MG BASE/GM;0.1%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE is listed in Drugs@FDA under application 062600 (ANDA).

Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE Form and strength CREAM;TOPICAL - EQ 3.5MG BASE/GM;0.1% Sponsor FOUGERA Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE is listed in Drugs@FDA under application 062600 (ANDA). Marketing status: Discontinued Active ingredient NEOMYCIN SULFATE; TRIAMCINOLONE ACETONIDE Form and strength CREAM;TOPICAL - EQ 3.5MG BASE/GM;0.1% Sponsor FOUGERA Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.